Scientists develop new drug treatment for TB Scientists have developed the first non-antibiotic drug to successfully treat tuberculosis in animals. The team hope the compound -developed after 10 years of painstaking research will be trialed on humans within three to four years
ATS joins U.S. Senators urging Trump administration to show leadership in global TB elimination efforts Today, the American Thoracic Society joined U.S. Senators Sherrod Brown (D-OH) and Todd Young (R-IN) and other senators in calling on the Trump administration to show leadership in global TB elimination efforts. Senators Brown and Young sent a bipartisan letter to President Trump urging the Administration to provide robust commitments, including for TB control and research and development programs, during the United Nations General Assembly's (UNGA) High-Level Meeting on Tuberculosis.
Complete makeover in fight of multidrug-resistant tuberculosis Several new medicines have been found to be more effective than traditional ones used to treat multidrug-resistant tuberculosis (MDR-TB), according to a new international collaborative study. These findings may precipitate a complete overhaul of worldwide TB treatment guidelines.
